VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 142 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,584,000 | +61.0% | 69,003 | +33.6% | 0.17% | +104.8% |
| Q2 2018 | $984,000 | +46.4% | 51,663 | +29.5% | 0.08% | +52.7% |
| Q1 2018 | $672,000 | -65.3% | 39,893 | -68.7% | 0.06% | -28.6% |
| Q4 2017 | $1,935,000 | +14.7% | 127,277 | +35.0% | 0.08% | -51.9% |
| Q3 2017 | $1,687,000 | -14.6% | 94,272 | -22.2% | 0.16% | -10.6% |
| Q2 2017 | $1,975,000 | +5.3% | 121,138 | -9.5% | 0.18% | -12.7% |
| Q1 2017 | $1,875,000 | +1.2% | 133,921 | +15.3% | 0.20% | -9.3% |
| Q4 2016 | $1,853,000 | +62.4% | 116,155 | +69.4% | 0.23% | +80.8% |
| Q3 2016 | $1,141,000 | – | 68,569 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |